The short version
Only one company currently supplies this market — there is no backup if it stumbles. Historically, drugs in this position went on to a new shortage within 90 days about 0.5% of the time — roughly 3× the typical drug (0.1%).
Market view
1 marketed package NDCs · 1 active manufacturer
Most dispensed: 40 mg/mL · Injection, Solution · #12 blister packs/carton / 1 syringe, glass in 1 blister pack / 1 ml in 1 syringe, glass · 20 mg/mL · Injection, Solution · #30 blister packs/carton / 1 syringe, glass in 1 blister pack / 1 ml in 1 syringe, glass · 40 mg/mL · Injection, Solution · #12 blister packs/carton / 1 syringe in 1 blister pack / 1 ml in 1 syringe · 20 mg/mL · Injection, Solution · #30 blister packs/carton / 1 syringe in 1 blister pack / 1 ml in 1 syringe
Only one company currently supplies this market — there is no backup if it stumbles. Historically, drugs in this position went on to a new shortage within 90 days about 0.5% of the time — roughly 3× the typical drug (0.1%).
Every detected change for glatiramer acetate, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.